In the United States, any cosmetic product that carries an SPF claim is regulated as an over-the-counter (OTC) drug by the Food and Drug Administration, not as a cosmetic. This regulatory classification applies regardless of how elegantly the product is marketed or how cosmetic its texture feels — the moment you print 'SPF 50' on the label, you are operating under OTC drug rules.
The practical implications for a private label founder are significant. First, your contract manufacturer must be registered with the FDA as a drug establishment and must operate under pharmaceutical current Good Manufacturing Practice (cGMP) regulations, specifically 21 CFR Parts 210 and 211. Not every cosmetic contract manufacturer holds this qualification — screening for OTC drug manufacturing capability is one of the first filters to apply when sourcing a manufacturing partner.
Second, the UV filter actives in your formula must be drawn exclusively from the FDA's OTC Sunscreen Monograph (21 CFR Part 352, now updated under the Coronavirus Aid, Relief, and Economic Security Act framework). Only certain active ingredients at specified maximum concentrations are permitted. As of current FDA guidance, only zinc oxide and titanium dioxide are categorized as Generally Recognized as Safe and Effective (GRASE) for sunscreen use. Several chemical UV filters remain in a 'not enough data' category, meaning their ongoing use is permitted under the existing monograph while the FDA continues to evaluate new data submissions from industry.
Third, your finished product label must include a Drug Facts panel formatted per FDA OTC labeling requirements — this is a specific box with required elements including active ingredients and their percentages, purposes, warnings, directions for use, and inactive ingredients. Standard cosmetic INCI labeling alone is not sufficient.
SPF efficacy testing is required. The FDA-recognized protocol for in-vivo SPF testing is the ISO 24444 method (previously the FDA's own protocol), conducted on human subjects. In-vitro testing methods exist and are widely used by indie brands at launch, but the FDA has not fully finalized its in-vitro testing framework under the new monograph rules, which introduces some regulatory uncertainty. Consulting with a regulatory affairs specialist before launch is strongly recommended.
Transexamic acid itself is not an FDA-regulated drug ingredient in this context — it is a cosmetic active. Its inclusion does not add to your OTC drug regulatory burden as long as your label does not make drug-level claims related to the TXA (e.g., 'treats melasma' would be a drug claim; 'visibly brightens lip tone' is a cosmetic claim).
For EU market entry, SPF lip products are regulated as cosmetics under EC 1223/2009, but UV filter selection is governed by Annex VI of that regulation — the approved list differs from the US monograph. A Responsible Person, a Cosmetic Product Safety Report, and notification in the CPNP portal are all required before selling in the EU.
AJ Cosmo Labs connects founders with manufacturers who already hold the relevant drug establishment registrations, shortcutting one of the most time-consuming parts of the sourcing process.
Ingredients in this answer: Titanium Dioxide · Zinc Oxide
Read the full guide on Private Label Tranexamic Acid SPF 50 Lip Treatment →